Safety and Efficacy of Dabigatran Etexilate vs Dose-Adjusted Warfarin in Patients With Cerebral Venous Thrombosis-Reference-Cited by-同舟云学术

Safety and Efficacy of Dabigatran Etexilate vs Dose-Adjusted Warfarin in Patients With Cerebral Venous Thrombosis

Published:2019-12-01 Issue:12 Volume:76 Page:1457
ISSN:2168-6149
Container-title:JAMA Neurology
language:en
Short-container-title:JAMA Neurol

Author:

Ferro José M.¹²,Coutinho Jonathan M.³,Dentali Francesco⁴,Kobayashi Adam⁵⁶,Alasheev Andrey⁷,Canhão Patrícia¹,Karpov Denis⁸,Nagel Simon⁹,Posthuma Laura³,Roriz José Mário¹⁰,Caria Jorge¹¹,Frässdorf Mandy¹²,Huisman Holger¹³,Reilly Paul¹⁴,Diener Hans-Christoph¹⁵,

Affiliation:

1. Department of Neurosciences and Mental Health, Serviço de Neurologia, Hospital Santa Maria/Centro Hospitalar Lisboa Norte, Lisbon, Portugal

2. Instituto de Medicina Molecular and Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal

3. Department of Neurology, Academic Medical Centre, Amsterdam, the Netherlands

4. Department of Clinical and Experimental Medicine, Insubria University, Varese, Italy

5. Faculty of Health Sciences and Physical Education, Kazimierz Pulaski University of Technology and Humanities Radom, Warsaw, Poland

6. Interventional Stroke and Cerebrovascular Disease Treatment Center, Institute of Psychiatry and Neurology, Warsaw, Poland

7. Sverdlovsk Regional Clinical Hospital No 1, Yekaterinburg, Russia

8. Neurology Department, Regional State Budget Healthcare, City Hospital No. 5, Barnaul, Russia

9. Department of Neurology, University Hospital Heidelberg, Heidelberg, Germany

10. Neurology Department, Centro Hospitalar de Entre o Douro e Vouga, Santa Maria da Feira, Portugal

11. Boehringer Ingelheim International, Ingelheim am Rhein, Germany

12. Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim am Rhein, Germany

13. Boehringer Ingelheim BV, Alkmaar, the Netherlands

14. Department of Clinical Development, Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, Connecticut

15. Faculty of Medicine, University Duisburg-Essen, Essen, Germany

Publisher

American Medical Association (AMA)

Subject

Clinical Neurology

Link

https://jamanetwork.com/journals/jamaneurology/articlepdf/2749167/jamaneurology_ferro_2019_oi_190070.pdf

Reference26 articles.

1. The incidence of cerebral venous thrombosis: a cross-sectional study.;Coutinho;Stroke,2012

2. Cerebral venous sinus thrombosis incidence is higher than previously thought: a retrospective population-based study.;Devasagayam;Stroke,2016

3. Cerebral vein and dural sinus thrombosis in adults in Isfahan, Iran: frequency and seasonal variation.;Janghorbani;Acta Neurol Scand,2008

4. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT).;Ferro;Stroke,2004

5. Venous thromboembolic events after cerebral vein thrombosis.;Miranda;Stroke,2010

Cited by 220 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cerebral venous sinus thrombosis as a complication of lumbar puncture;Thrombosis Update;2024-09

2. Practical Prescribing: Direct oral anticoagulants;BMJ;2024-08-30

3. Cerebral Vein Thrombosis and Direct Oral Anticoagulants: A Review;Journal of Clinical Medicine;2024-08-12

4. Effect of direct oral anticoagulants in patients with cerebral venous thrombosis;European Journal of Internal Medicine;2024-08

5. Advances in Cerebral Venous Thrombosis;Stroke;2024-08